Wednesday, June 19, 2013

Losing Weight While Injured

I recently tore my meniscus, and I need surgery following by crutches and physical therapy.

I used to play intensive sports three hours a day, every day of the week so calories and exercising were never really a huge problem for me.

Just within the past week that I've been off of exercise, I've gained a lot of weight and I almost feel myself losing muscle (maybe its all just psychological ;P) But still, if anyone has any tips for exercising, losing weight, or maintaining muscle while injured, please share!


View the original article here

Rosie Fortescue at the AllSaints Biker Project


Rosie Fortescue wears a black fedora hat, beige trench coat, skinny leather trousers and a black Celine bag to the AllSaints Biker Project exhibition in London - vote on celebrity fashion, style and red carpet looks in GLAMOUR.COM’s Dos and Don’ts

Continue reading...

View the original article here

Ant & Dec bag UK No.1 with 19-year-old hit


Ant & Dec have bagged themselves a No1 slot with their 1994 hit Let’s Get Ready To Rhumble after they performed the song on Saturday Night Takeaway.

Continue reading...

View the original article here

10 Foods for Children's Brain Development

By Anne Krueger
WebMD FeatureReviewed by Patricia Quinn, MD

As fast as children whiz from classroom to activity to home and back again, their brains are just as actively and dramatically growing and changing.

"These years are critical for brain development, and what they eat affects focus and cognitive skills," psychiatrist Drew Ramsey, MD, coauthor of The Happiness Diet, says. 

Food is one of many factors that affect a child's brain development.

The following 10 foods can help kids stay sharp all day long, and affect brain development well into the future.

Eating a high-nutrient protein like eggs (which have nutrients including choline, omega-3s, zinc, and lutein) will help kids concentrate, Beth Saltz, RD, says. 

How to Serve It:  Fold scrambled eggs into a whole-grain tortilla for a filling breakfast or late-afternoon snack. "The protein-carb combo tides kids over until the next meal with no sugar-induced energy crash," Saltz says.

Fat is important to brain health, says Laura Lagano, RD. A full-fat Greek yogurt (which has more protein that other yogurts) can help keep brain cell membranes flexible, helping them to send and receive information.

How to Serve It: Pack Greek yogurt in lunch with some fun mix-ins: cereal with at least 3 grams of fiber and blueberries for a dose of nutrients called polyphenols. 

Or add a few dark chocolate chips. Polyphenols in cocoa are thought to keep the mind sharp by hiking brain blood flow.

Full of folate and vitamins, spinach and kale are part of a healthy diet linked to lower odds of getting dementia later in life. "Kale contains sulforaphane, a molecule that has detoxifying abilities, and diindolylmethane, which helps new brain cells grow," says Ramsey, coauthor of 50 Shades of Kale.

How to Serve It:

Whip spinach into smoothies for snack time.Add it to omelets.Saute it at dinner drizzled with olive oil (the dash of fat helps your body absorb vitamins).

Make chips out of kale: Cut kale from stems/ribs, drizzle with olive oil and a bit of salt, and bake.

Low in sugar, high in fiber, and full of folate and B6 that help regulate mood, memory, and attention, purple cauliflower also delivers inflammation-fighting nutrients called anthocyanins. 

How to Serve It: Roast and puree cauliflower to make a nutritious dipping sauce for carrots and other veggies such as peppers, celery, and radishes.

Naturally fatty fish are a good source of vitamin D and omega-3s, which protect the brain against cognitive decline and memory loss. Salmon, tuna, and sardines are all rich in omega-3s.  

"The more omega-3s we can get to the brain, the better it will function and the better kids will be able to focus," says Bonnie Taub-Dix, RD, author of Read It Before You Eat It.

How to Serve It: Grill it, roast it, or add it to a salad or sandwich.  


View the original article here

Simple Breath Test Might Diagnose Heart Failure

Noninvasive method found accurate in small, early studyResults surprise, disappoint scientists.

By Alan Mozes

HealthDay Reporter

MONDAY, March 25 (HealthDay News) -- An experimental breath test, designed to quickly identify patients suffering from heart failure simply by analyzing the contents of a single exhaled breath, has demonstrated promise in early trials, a team of researchers says.

The investigators stressed that their evaluation is based on a small group of participating patients, and that more extensive research will have to be done to confirm their initial success.

But by subjecting a patient's breath to a rigorous but fast analysis of the hundreds of so-called volatile organic compounds contained therein, the study team said it has so far been able to correctly diagnose heart failure among newly hospitalized patients with a 100 percent accuracy.

"Every individual has a breath print that differentiates them from other people, depending on what's going on in their body," explained study lead author Dr. Raed Dweik, a staff physician in the department of pulmonary, allergy and critical care medicine with the Respiratory Institute at Cleveland Clinic. "And that print can tell us a lot about a person, what they've been exposed to and what disease they have," he added.

"That's what makes the new field of breath testing so promising, because it is non-intrusive, so there is no risk involved," Dweik said. "And you can do it anywhere, in a clinic, in a hospital, anywhere."

The findings were published March 25 in the Journal of the American College of Cardiology.

The study authors pointed out that the most common reason American patients are admitted to a hospital is when there is a suspicion of heart failure -- a tough-to-treat condition in which the heart's pumping action grows gradually weaker over time.

Currently, a diagnosis of heart failure comes from a variety of factors, according to the U.S. National Heart, Lung, and Blood Institute. These include medical history and symptoms, and a physical exam in which a doctor will listen to a patient's heart and lung sounds, and check ankles, feet, legs and abdomen for signs of fluid buildup. Blood tests and an electrocardiogram can help confirm that heart failure exists.

In the new study, to gauge how well the noninvasive breath test could identify heart failure, the team collected exhaled breath samples from 41 patients who had been admitted as in-patients to the Cleveland Clinic.

Of those, 25 had been admitted with a primary diagnosis of "acute decompensated heart failure" while another 16 patients had shown no signs of heart failure but did have other cardiovascular issues. A single breath sample was obtained from each of the patients within 24 hours of admission, as well as from an additional 36 patients with acute decompensated heart failure as an independent point of comparison.


View the original article here

Comparing the New Blood Thinners to Warfarin

blood cells

May 31, 2013 -- More than 2 million Americans have an abnormal heart rhythm known as atrial fibrillation, raising their risk of blood clots leading to stroke. For many years, the blood thinner Coumadin (warfarin) was the only game in town to help lower that stroke risk.

In the past 3 years, though, three new blood thinners, also called anticoagulants, have been FDA-approved for atrial fibrillation.

WebMD asked two doctors to  compare them to warfarin and describe the risks and benefits of each. Neither doctor has ties to the drug companies making the blood thinners.

All three new drugs are approved for atrial fibrillation treatment in people who do not have heart valve problems or artificial valves.  One of the three also has FDA approval for additional conditions.

Atrial fibrillation disrupts the flow of blood through the heart. As blood pools, it's more likely to form clots that can travel to the brain, causing a stroke.

The new drugs are different in some respects but work in the same general way. ''All of them work on the clotting 'cascade,'" says John Doherty, MD. He is a professor of medicine at the Thomas Jefferson University School of Medicine, Philadelphia, and a member of the American College of Cardiology's Anticoagulation Initiative.

That cascade ''is a series of events by which different compounds are generated and ultimately result in blood coagulation [clotting]."

The three new drugs, which target various points along that cascade, include:

Pradaxa (dabigatran).It was approved by the FDA in October 2010 for prevention of stroke and blood clots in people with atrial fibrillation.

Xarelto (rivaroxaban). It was approved in November 2011, to treat atrial fibrillation. It had been approved earlier to lower the risk of blood clots after hip and knee replacements.

In November 2012, the FDA also approved it to treat deep vein thrombosis, (blood clots that occur usually in the lower leg and thigh) and pulmonary embolism (the condition that results when a blood clot from a vein breaks off and travels to an artery in the lungs and blocks blood flow.)

Eliquis (apixaban). It was approved in December 2012 to lower the risk of stroke and dangerous blood clots in patients with atrial fibrillation.

"We are excited there are these new options, but each patient will have to have a conversation with their physician and decide what is appropriate for them," says Clyde Yancy, MD. Yancy is chief of cardiology at Feinberg School of Medicine, Northwestern University, and past president of the American Heart Association.

While the new drugs offer some benefits over warfarin, some patients may do better to stay on the old drug if they are doing well, says Doherty.

Yancy agrees. "If you are doing well on warfarin, there is no reason to take a more expensive drug unless the other advantages are so uniquely important it's worth the transition," he says.


View the original article here

U.S. Agency Puts Poison Prevention in Spotlight

Title: U.S. Agency Puts Poison Prevention in Spotlight
Category: Health News
Created: 3/24/2013 10:35:00 AM
Last Editorial Review: 3/25/2013 12:00:00 AM

View the original article here